AR and adenocarcinoma: Genetically engineered mouse models carrying overexpression of both AR and Src, but not alone, in normal prostate epithelial cells, can induce poorly or non-differentiated adenocarcinoma (98), supporting co-activation of AR and Src is required for prostate tumourigenesis.